Lilly to Participate in Barclays Global Healthcare Conference | Eli Lilly and Company
INDIANAPOLIS, March 9, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) will participate in the Barclays Global Healthcare Conference on
Read moreEli Lilly
Addressing Migraine Care Gaps to Enable Gender Equality
On International Women’s Day 2020, we are taking the opportunity to shine a light on women who live with migraine
Read moreBuilding an inclusive and equitable workplace
We are proud, at Lilly, of our commitment to equal gender representation at every level of the company. We believe
Read moreA Comment On PMPRB Regulations
Today’s blog comes from Lilly Canada’s new President and General Manager, Rhonda Pacheco. This was drawn verbatim from a statement
Read moreLilly Statement on Novel Coronavirus and the Reliable Supply of the Company’s Medicines | Eli Lilly and Company
INDIANAPOLIS, March 3, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) issued the following statement today regarding the novel
Read moreU.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis | Eli Lilly and Company
NEW YORK and INDIANAPOLIS, March 2, 2020 /PRNewswire/ — Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that
Read moreEli Lilly and Company Statement on ICER Final Report for Acute Treatments for Migraine: Effectiveness and Value | Eli Lilly and Company
INDIANAPOLIS, February 28, 2020 – Eli Lilly and Company shared the following statement in response to the Institute for Clinical
Read moreRemembering Alzheimer’s Advocate and Patient, B. Smith
Earlier this week, the world lost an important advocate for people with Alzheimer’s disease: restauranteur and author B. Smith. Smith
Read moreFDA Advisory Committee Votes in Favor of Lilly’s CYRAMZA® (ramucirumab) as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer | Eli Lilly and Company
INDIANAPOLIS, Feb. 26, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that a U.S. Food and Drug
Read moreLilly To Participate in SVB Leerink Global Healthcare Conference | Eli Lilly and Company
INDIANAPOLIS, Feb. 21, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will participate in the 9th Annual SVB Leerink
Read moreTrulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease | Eli Lilly and Company
INDIANAPOLIS, Feb. 21, 2020/PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major
Read moreLilly to Participate in Cowen Health Care Conference | Eli Lilly and Company
INDIANAPOLIS, Feb. 21, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 40th Annual
Read moreLilly Completes Acquisition of Dermira | Eli Lilly and Company
INDIANAPOLIS, Feb. 20, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of
Read moreInvesting in Innovation and Jobs
For more than 140 years, Lilly has researched, discovered, and manufactured life-saving medicines for people around the world. Making medicines
Read moreHow We’re Making Health Care More Affordable for Employees
Today’s guest blog comes from Dave Ricks, Lilly Chairman and CEO. Beginning this year, Lilly’s health plan cut patients’ costs
Read moreLilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study | Eli Lilly and Company
INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the analysis performed by Washington University
Read moreLilly to Participate in Guggenheim Healthcare Talks Idea Forum | Eli Lilly and Company
INDIANAPOLIS, Feb. 7, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Healthcare Talks Idea Forum
Read moreLilly’s REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription | Eli Lilly and Company
INDIANAPOLIS, Jan. 31, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that REYVOW™ (lasmiditan) C-V 50 mg and 100
Read moreCHMP Recommends Approval of Lilly’s New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes | Eli Lilly and Company
INDIANAPOLIS, Jan. 31, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency’s (EMA) Committee
Read moreImproving Diabetes Care
As part of Lilly’s commitment to identify gaps in the health care system and find solutions that help people with
Read moreLilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis | Eli Lilly and Company
INDIANAPOLIS, Jan. 30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that baricitinib
Read moreLilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition | Eli Lilly and Company
INDIANAPOLIS, Jan. 30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter
Read moreLilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities | Eli Lilly and Company
INDIANAPOLIS, Jan. 28, 2020 /PRNewswire/ — Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least 200,000
Read moreLilly Receives FDA Priority Review for the Selpercatinib New Drug Application | Eli Lilly and Company
INDIANAPOLIS, Jan. 29, 2020/PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration
Read moreAnat Hakim to join Lilly as General Counsel | Eli Lilly and Company
INDIANAPOLIS, Jan. 24, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that Anat Hakim will join the
Read more